Identification of t(17;22)(q22;q13) (COL1A1/PDGFB) in dermatofibrosarcoma protuberans by fluorescence in situ hybridization in paraffin-embedded tissue microarrays

Human Pathology

Volumn 42, Issue 2, 2011, Pages 176-184

  Segura, Sonia ^a   Salgado, Rocío ^a   Toll, Agustí ^a   Martín Ezquerra, Gemma ^a   Yébenes, Mireia ^b   Sáez, Amparo ^c   Solé, Francesc ^a   Barranco, Carlos ^a   Umbert, Pablo ^d   Espinet, Blanca ^a   Pujol, Ramón M ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b Parc Tauli Health Corporation   (Spain)

^c HOSPITAL DE SABADELL   (Spain)

^d HOSPITAL UNIVERSITARI SAGRAT COR   (Spain)

Author keywords

Dermatofibrosarcoma protuberans; Dermatopathology; Fluorescence in situ hybridization; Tissue microarrays

Indexed keywords

PARAFFIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHROMOSOME TRANSLOCATION 17; CHROMOSOME TRANSLOCATION 22; CLINICAL ARTICLE; CLINICAL FEATURE; COL1A1 GENE; CONTROLLED STUDY; CYTOLOGY; DERMATOFIBROMA; DERMATOFIBROSARCOMA PROTUBERANS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE; GENE REARRANGEMENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PDGFB GENE; TISSUE MICROARRAY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 22; COLLAGEN TYPE I; DERMATOFIBROSARCOMA; FEMALE; HISTIOCYTOMA, BENIGN FIBROUS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; ONCOGENE PROTEINS, FUSION; PARAFFIN EMBEDDING; PROTO-ONCOGENE PROTEINS C-SIS; TISSUE ARRAY ANALYSIS; TRANSLOCATION, GENETIC; YOUNG ADULT;

EID: 78751585126     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2010.07.015     Document Type: Article

References (30)

1. Gloster H.M. Jr Dermatofibrosarcoma protuberans J Am Acad Dermatol 35 1996 355 374
2. Rutgers E.J., Kroon B.B., Albus-Lutter C.E., and Gortzak E. Dermatofibrosarcoma protuberans: treatment and prognosis Eur J Surg Oncol 18 1992 241 248
3. Aiba S., Tabata N., Ishii H., Ootani H., and Tagami H. Dermatofibrosarcoma protuberans is a unique fibrohistiocytic tumour expressing CD34 Br J Dermatol 127 1992 79 84
4. Kutzner H. Expression of the human progenitor cell antigen CD34 (HPCA-1) distinguishes dermatofibrosarcoma protuberans from fibrous histiocytoma in formalin-fixed, paraffin-embedded tissue J Am Acad Dermatol 28 1993 613 617
5. Abenoza P., and Lillemoe T. CD34 and factor XIIIa in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans Am J Dermatopathol 15 1993 429 434
6. Bridge J.A., Neff J.R., and Sandberg A.A. Cytogenetic analysis of dermatofibrosarcoma protuberans Cancer Genet Cytogenet 49 1990 199 202
7. Mandahl N., Heim S., Willén H., Rydholm A., and Mitelman F. Supernumerary ring chromosome as the sole cytogenetic abnormality in a dermatofibrosarcoma protuberans Cancer Genet Cytogenet 49 1990 273 275
8. Pedeutour F., Coindre J.M., Nicolo G., Bouchot C., Ayraud N., and Carel C.T. Ring chromosomes in dermatofibrosarcoma protuberans contain chromosome 17 sequences: fluorescence in situ hybridization Cancer Genet Cytogenet 67 1993 149
9. Minoletti F., Miozzo M., and Pedeutour F. Involvement of chromosomes 17 and 22 in dermatofibrosarcoma protuberans Genes Chromosomes Cancer 13 1995 62 65
10. Naeem R., Lux M.L., Huang S.F., Naber S.P., Corson J.M., and Fletcher J.A. Ring chromosomes in dermatofibrosarcoma protuberans are composed of interspersed sequences from chromosomes 17 and 22 Am J Pathol 147 1995 1553 1558
11. Pedeutour F., Simon M.P., and Minoletti F. Ring 22 chromosomes in dermatofibrosarcoma protuberans are low-level amplifiers of chromosome 17 and 22 sequences Cancer Res 55 1995 2400 2403
12. Pedeutour F., Simon M.P., and Minoletti F. Translocation, t(17;22)(q22;q13), in dermatofibrosarcoma protuberans: a new tumor-associated chromosome rearrangement Cytogenet Cell Genet 72 1996 171 174
13. Simon M.P., Pedeutour F., and Sirvent N. Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma Nat Genet 15 1997 95 98
14. Sjoblom T., Shimizu A., and O'Brien K.P. Growth inhibition of dermatofibrosarcoma protuberans tumors by the platelet-derived growth factor receptor antagonist STI571 through induction of apoptosis Cancer Res 61 2001 5778 5783
15. Rubin B.P., Schuetze S.M., and Eary J.F. Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans J Clin Oncol 20 2002 3586 3591
16. McArthur G.A., Demetri G.D., and van Oosterom A. Molecular and clinical analysis of locally advanced Dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225 J Clin Oncol 23 2005 866 873
17. Patel K.U., Szabo S.S., and Hernandez V.S. Dermatofibrosarcoma protuberans COL1A1-PDGFB fusion is identified in virtually all dermatofibrosarcoma protuberans cases when investigated by newly developed multiplex reverse transcription polymerase chain reaction and fluorescence in situ hybridization assays Hum Pathol 39 2008 184 193
18. Craver R., Dewenter T., Ebran N., and Pedeutour F. COL1A1-PDGFB fusion in a pediatric Bednar tumor with 2 copies of a der(22)t(17;22) Cancer Genet Cytogenet 168 2006 155 157
19. Abbott J.J., Erickson-Johnson M., Wang X., Nascimento A.G., and Oliveira A.M. Gains of COL1A1-PDGFB genomic copies occur in fibrosarcomatous transformation of dermatofibrosarcoma protuberans Mod Pathol 19 2006 1512 1518
20. Maire G., Fraitag S., and Galmiche L. A clinical, histologic, and molecular study of 9 cases of congenital dermatofibrosarcoma protuberans Arch Dermatol 143 2007 203 210
21. Macarenco R.S., Zamolyi R., and Franco M.F. Genomic gains of COL1A1/PDFGB occur in the histologic evolution of giant cell fibroblastoma into dermatofibrosarcoma protuberans Genes Chromosomes Cancer 47 2008 260 265
22. Kononen J., Bubendorf L., and Kallioniemi A. Tissue microarrays for high-throughput molecular profiling of tumor specimens Nat Med 4 1998 844 847
23. Llombart B., Sanmartín O., and López-Guerrero J.A. Dermatofibrosarcoma protuberans: clinical, pathological, and genetic (COL1A1-PDGFB) study with therapeutic implications Histopathology 54 2009 860 872
24. Takahira T., Oda Y., and Tamiya S. Detection of COL1A1-PDGFB fusion transcripts and PDGFB/PDGFRB mRNA expression in dermatofibrosarcoma protuberans Mod Pathol 20 2007 668 675
25. Gökden N., Dehner L.P., Zhu X., and Pfeifer J.D. Dermatofibrosarcoma protuberans of the vulva and groin: detection of COL1A1-PDGFB fusion transcripts by RT-PCR J Cutan Pathol 2003 30190 30195
26. Giacchero D., Maire G., and Nuin P.A. No correlation between the molecular subtype of COL1A1-PDGFB fusion gene and the clinico-histopathological features of dermatofibrosarcoma protuberans J Invest Dermatol 130 2009 904 907
27. Horenstein M.G., Prieto V.G., Nuckols J.D., Burchette J.L., and Shea C.R. Indeterminate fibrohistiocytic lesions of the skin: is there a spectrum between dermatofibroma and dermatofibrosarcoma protuberans? Am J Surg Pathol 24 2000 996 1003
28. Wang W.L., Patel K.U., and Coleman N.M. COL1A1:PDGFB chimeric transcripts are not present in indeterminate fibrohistiocytic lesions of the skin Am J Dermatopathol 32 2010 149 153
29. Kiuru-Kuhlefelt S., El-Rifai W., Fanburg-Smith J., Kere J., Miettinen M., and Knuutila S. Concomitant DNA copy number amplification at 17q and 22q in dermatofibrosarcoma protuberans Cytogenet Cell Genet 92 2001 192 195
30. Wang J., Morimitsu Y., and Okamoto S. COL1A1-PDGFB fusion transcripts in fibrosarcomatous areas of six dermatofibrosarcomas protuberans J Mol Diagn 2 2000 47 52